Top

Journal of Experimental & Clinical Cancer Research

Published in:

Open Access 01-12-2021 | Correction

Correction to: MicroRNA-224 sustains Wnt/β-catenin signaling and promotes aggressive phenotype of colorectal cancer

Authors: Tingting Li, Qiuhua Lai, Shuyang Wang, Juanjuan Cai, Zhiyuan Xiao, Danling Deng, Liuqing He, Hongli Jiao, Yaping Ye, Li Liang, Yanqing Ding, Wenting Liao

Published in: Journal of Experimental & Clinical Cancer Research | Issue 1/2021

Excerpt

Correction to: J Exp Clin Cancer Res 35, 21 (2016) …

Li T, Lai Q, Wang S, et al. MicroRNA-224 sustains Wnt/β-catenin signaling and promotes aggressive phenotype of colorectal cancer. J Exp Clin Cancer Res. 2016;35:21. https://doi.org/10.1186/s13046-016-0287-1.CrossRefPubMedPubMedCentral

Title: Correction to: MicroRNA-224 sustains Wnt/β-catenin signaling and promotes aggressive phenotype of colorectal cancer
Authors: Tingting Li
Qiuhua Lai
Shuyang Wang
Juanjuan Cai
Zhiyuan Xiao
Danling Deng
Liuqing He
Hongli Jiao
Yaping Ye
Li Liang
Yanqing Ding
Wenting Liao
Publication date: 01-12-2021
Publisher: BioMed Central
Published in: Journal of Experimental & Clinical Cancer Research / Issue 1/2021
Electronic ISSN: 1756-9966
DOI: https://doi.org/10.1186/s13046-021-01945-3

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2021

Underlying mechanisms and drug intervention strategies for the tumour microenvironment

Correction to: Current status of ctDNA in precision oncology for hepatocellular carcinoma

Correction to: Pre-metastatic niche triggers SDF-1/CXCR4 axis and promotes organ colonisation by hepatocellular circulating tumour cells via downregulation of Prrx1

Empty spiracles homeobox genes EMX1 and EMX2 regulate WNT pathway activation in sarcomagenesis

Modelling hypersensitivity to trastuzumab defines biomarkers of response in HER2 positive breast cancer

METTL3-mediated m6A mRNA modification of FBXW7 suppresses lung adenocarcinoma

Keynote webinar | Spotlight on antibody–drug conjugates in cancer